OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SURI56

Maja Agung Latexindo PT Tbk

Medical Equipment, Supplies & DistributionVerified

Maja Agung Latexindo PT Tbk has a current ratio of 4.83, indicating strong short-term liquidity, but its free cash flow is negative at -994.1 million IDR, and operating cash flow is only 1.05 billion IDR, suggesting limited capacity to fund operations without external financing. The company’s debt-to-equity ratio is 0.0, reflecting no long-term debt, but its net cash position is negative after subtracting total debt, signaling potential liquidity risk. The company’s profitability is weak, with a return on equity of -0.99% and a return on assets of -0.87%, both significantly below the industry median for medical equipment and supplies firms, which typically report positive ROE and ROA in the 5-10% range. Operating income is negative at -4.76 billion IDR, and net income is -3.38 billion IDR, indicating a failure to generate earnings despite revenue of 150.2 billion IDR. The company operates in two segments: Gloves and Concentrated Latex. Revenue concentration data is not disclosed, but the company serves domestic and international markets, including healthcare, industrial, and personal care sectors. Geographic exposure is primarily in Indonesia, with operations in Deli Serdang and North Labuhan Batu Regencies, North Sumatra. Growth trajectory is unclear due to the absence of forward-looking guidance in the input data. Historical revenue of 150.2 billion IDR is flat compared to prior periods, and the company has not disclosed segment-level growth rates. Outlook data for the current and next fiscal years is not provided, limiting visibility into future performance. Risk factors include medium liquidity risk due to negative free cash flow and a negative net cash position, as well as a low dilution risk score. No dilution sources are disclosed in the input data, and no adjustments are applied in custom valuations. Recent events include no disclosed filings or transcripts in the input data. The company’s financial performance in the latest period shows deteriorating profitability, with operating and net losses, but no material events are reported to explain the decline.

30-day price · SURI+12.00 (+17.9%)
Low$59.00High$100.00Close$79.00As of13 May, 00:00 UTC
Profile
CompanyMaja Agung Latexindo PT Tbk
TickerSURI.JK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Maja Agung Latexindo PT Tbk produces disposable medical gloves and concentrated latex for healthcare, industrial, and personal care markets, primarily in Indonesia and internationally.

Classification. Classified in the industry "Medical Equipment, Supplies & Distribution" under the Healthcare Services & Equipment business sector, with 92% confidence.

Maja Agung Latexindo PT Tbk has a current ratio of 4.83, indicating strong short-term liquidity, but its free cash flow is negative at -994.1 million IDR, and operating cash flow is only 1.05 billion IDR, suggesting limited capacity to fund operations without external financing. The company’s debt-to-equity ratio is 0.0, reflecting no long-term debt, but its net cash position is negative after subtracting total debt, signaling potential liquidity risk. The company’s profitability is weak, with a return on equity of -0.99% and a return on assets of -0.87%, both significantly below the industry median for medical equipment and supplies firms, which typically report positive ROE and ROA in the 5-10% range. Operating income is negative at -4.76 billion IDR, and net income is -3.38 billion IDR, indicating a failure to generate earnings despite revenue of 150.2 billion IDR. The company operates in two segments: Gloves and Concentrated Latex. Revenue concentration data is not disclosed, but the company serves domestic and international markets, including healthcare, industrial, and personal care sectors. Geographic exposure is primarily in Indonesia, with operations in Deli Serdang and North Labuhan Batu Regencies, North Sumatra. Growth trajectory is unclear due to the absence of forward-looking guidance in the input data. Historical revenue of 150.2 billion IDR is flat compared to prior periods, and the company has not disclosed segment-level growth rates. Outlook data for the current and next fiscal years is not provided, limiting visibility into future performance. Risk factors include medium liquidity risk due to negative free cash flow and a negative net cash position, as well as a low dilution risk score. No dilution sources are disclosed in the input data, and no adjustments are applied in custom valuations. Recent events include no disclosed filings or transcripts in the input data. The company’s financial performance in the latest period shows deteriorating profitability, with operating and net losses, but no material events are reported to explain the decline.
Key takeaways
  • Maja Agung Latexindo PT Tbk is a medical glove manufacturer with weak profitability and negative net income.
  • The company has no long-term debt but faces liquidity challenges due to negative free cash flow.
  • Revenue is concentrated in Indonesia, with no disclosed segment or geographic diversification metrics.
  • No forward-looking guidance is available, limiting visibility into growth or recovery potential.
  • --
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyIDR
Revenue$150.24B
Gross profit$8.05B
Operating income-$4.76B
Net income-$3.38B
R&D
SG&A
D&A
SBC
Operating cash flow$1.05B
CapEx-$942.3M
Free cash flow-$994.1M
Total assets$386.50B
Total liabilities$46.04B
Total equity$340.46B
Cash & equivalents
Long-term debt$1.58B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$340.46B
Net cash-$1.58B
Current ratio4.8
Debt/Equity0.0
ROA-0.9%
ROE-1.0%
Cash conversion-31.0%
CapEx/Revenue-0.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
MetricSURIActivity
Op margin-3.2%13.3% medp25 5.9% · p75 13.5%bottom quartile
Net margin-2.2%8.6% medp25 2.7% · p75 12.7%bottom quartile
Gross margin5.4%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-0.6%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity0.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 14:07 UTC#d90f048b
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 19:18 UTCJob: d3f3416e